{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:15:58Z","timestamp":1762506958774},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10067-016-3494-4","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T05:59:10Z","timestamp":1481349550000},"page":"885-894","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3\u00a0months duration) rheumatoid arthritis"],"prefix":"10.1007","volume":"36","author":[{"given":"Georgia","family":"Barouta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina G.","family":"Katsiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areti","family":"Varna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios E.","family":"Germenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"3494_CR1","first-page":"55","volume":"69","author":"DL Scott","year":"2004","unstructured":"Scott DL (2004) Radiological progression in established rheumatoid arthritis. J Rheumatol Suppl 69:55\u201365","journal-title":"J Rheumatol Suppl"},{"key":"3494_CR2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.autrev.2014.08.012","volume":"13","author":"LI Sakkas","year":"2014","unstructured":"Sakkas LI, Bogdanos DP, Katsiari CG, Platsoucas CD (2014) Anti-citrullinated peptides as autoantigens in rheumatoid arthritis\u2014relevance to treatment. Autoimmun Rev 13:1114\u20131120. doi: 10.1016\/j.autrev.2014.08.012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3494_CR3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","volume":"67","author":"SW Syversen","year":"2008","unstructured":"Syversen SW, Gaarder PI, Goll GL, \u00d8deg\u00e5rd S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landew\u00e9 R, Kvien TK (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67(2):212\u2013217","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3494_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.054445","volume":"66","author":"C Turesson","year":"2007","unstructured":"Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, R\u00f6nnelid J (2007) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66(1):59\u201364","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3494_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10067-007-0800-1","volume":"27","author":"I Alexiou","year":"2008","unstructured":"Alexiou I, Germenis A, Koutroumpas A, Kontogianni A, Theodoridou K, Sakkas LI (2008) Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 27(4):511\u2013513. doi: 10.1007\/s10067-007-0800-1","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3494_CR6","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588. doi: 10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3494_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.autrev.2009.11.017","volume":"9","author":"K Conrad","year":"2010","unstructured":"Conrad K, Roggenbuck D, Reinhold D, D\u00f6rner T (2010) Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 9(6):431\u2013435. doi: 10.1016\/j.autrev.2009.11.017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3494_CR8","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Despr\u00e9s N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, M\u00e9nard HA (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6(2):R142\u2013R150","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3494_CR9","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","volume":"56","author":"H Bang","year":"2007","unstructured":"Bang H, Egerer K, Gauliard A, L\u00fcthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56(8):2503\u20132511","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3494_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.23188","volume":"58","author":"L Mathsson","year":"2008","unstructured":"Mathsson L, Mullazehi M, Wick MC, Sj\u00f6berg O, van Vollenhoven R, Klareskog L, R\u00f6nnelid J (2008) Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 58(1):36\u201345. doi: 10.1002\/art.23188","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3494_CR11","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/ar2570","volume":"10","author":"P Nicaise Roland","year":"2008","unstructured":"Nicaise Roland P, Grootenboer Mignot S, Bruns A, Hurtado M, Palazzo E, Hayem G, Dieud\u00e9 P, Meyer O, Chollet Martin S (2008) Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res Ther 10(6):R142. doi: 10.1186\/ar2570","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3494_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/ard.2009.118448","volume":"69","author":"K Raza","year":"2010","unstructured":"Raza K, Mathsson L, Buckley CD, Filer A, R\u00f6nnelid J (2010) Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis. Ann Rheum Dis 69(3):627\u2013628. doi: 10.1136\/ard.2009.118448","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3494_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.autrev.2012.02.015","volume":"11","author":"E Bartoloni","year":"2012","unstructured":"Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R, Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators (2012) Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 11(11):815\u2013820. doi: 10.1016\/j.autrev.2012.02.015","journal-title":"Autoimmun Rev"},{"issue":"10","key":"3494_CR14","first-page":"1974","volume":"22","author":"A Larsen","year":"1995","unstructured":"Larsen A (1995) How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 22(10):1974\u20131975","journal-title":"J Rheumatol"},{"issue":"6","key":"3494_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","volume":"75","author":"M Juarez","year":"2016","unstructured":"Juarez M, Bang H, Hammar F, Reimer U, Dyke B, Sahbudin I, Buckley CD, Fisher B, Filer A, Raza K (2016) Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis. Ann Rheum Dis 75(6):1099\u20131107. doi: 10.1136\/annrheumdis-2014-206785","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3494_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3899\/jrheum.101086","volume":"38","author":"A Sv\u00e4rd","year":"2011","unstructured":"Sv\u00e4rd A, Kastbom A, S\u00f6derlin MK, Reckner-Olsson \u00c5, Skogh T (2011) A Comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. J Rheumatol 38(7):1265\u20131272. doi: 10.3899\/jrheum.101086","journal-title":"J Rheumatol"},{"issue":"8","key":"3494_CR17","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"MP Linden van der","year":"2009","unstructured":"van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH (2009) Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum 60(8):2232\u20132241. doi: 10.1002\/art.24716","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3494_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.humimm.2012.01.007","volume":"73","author":"L Sizova","year":"2012","unstructured":"Sizova L (2012) Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis. Hum Immunol 73(4):389\u2013392. doi: 10.1016\/j.humimm.2012.01.007","journal-title":"Hum Immunol"},{"issue":"6","key":"3494_CR19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3899\/jrheum.080796","volume":"36","author":"X Liu","year":"2009","unstructured":"Liu X, Jia R, Zhao J, Li Z (2009) The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol 36(6):1136\u20131142. doi: 10.3899\/jrheum.080796","journal-title":"J Rheumatol"},{"issue":"5","key":"3494_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3899\/jrheum.101143","volume":"38","author":"AM El-Barbary","year":"2011","unstructured":"El-Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA (2011) Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J Rheumatol 38(5):828\u2013834. doi: 10.3899\/jrheum.101143","journal-title":"J Rheumatol"},{"issue":"6","key":"3494_CR21","first-page":"1002","volume":"35","author":"L Innala","year":"2008","unstructured":"Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR (2008) Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24\u00a0months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol 35(6):1002\u20131008","journal-title":"J Rheumatol"},{"issue":"2","key":"3494_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.2008.103283","volume":"69","author":"JJ Luime","year":"2010","unstructured":"Luime JJ, Colin EM, Hazes JM, Lubberts E (2010) Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis 69(2):337\u2013344. doi: 10.1136\/ard.2008.103283","journal-title":"Ann Rheum Dis"},{"key":"3494_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CMAMD.S4827","volume":"3","author":"HE Mansour","year":"2010","unstructured":"Mansour HE, Metwaly KM, Hassan IA, Elshamy HA, Elbeblawy MM (2010) Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection. Clin Med Insights Arthritis Musculoskelet Disord 3:33\u201342","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"3","key":"3494_CR24","first-page":"702","volume":"4","author":"B Yousefghahari","year":"2013","unstructured":"Yousefghahari B, Alhooei S, Soleimani-Amiri MJ, Guran A (2013) Comparison of sensitivity and specificity of anti-CCP and anti-MCV antibodies in an Iranian cohort of patients with rheumatoid arthritis. Caspian J Intern Med 4(3):702\u2013706","journal-title":"Caspian J Intern Med"},{"key":"3494_CR25","doi-asserted-by":"publisher","first-page":"198198","DOI":"10.1155\/2014\/198198","volume":"2014","author":"ML D\u00edaz-Toscano","year":"2014","unstructured":"D\u00edaz-Toscano ML, Olivas-Flores EM, Zavaleta-Mu\u00f1iz SA, Gamez-Nava JI, Cardona-Mu\u00f1oz EG, Ponce-Guarneros M, Castro-Contreras U, Nava A, Salazar-Paramo M, Celis A, Fajardo-Robledo NS, Corona-Sanchez EG, Gonzalez-Lopez L (2014) Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing. Biomed Res Int 2014:198198. doi: 10.1155\/2014\/198198","journal-title":"Biomed Res Int"},{"issue":"3","key":"3494_CR26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","volume":"53","author":"D Coenen","year":"2007","unstructured":"Coenen D, Verschueren P, Westhovens R, Bossuyt X (2007) Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 53(3):498\u2013504","journal-title":"Clin Chem"},{"issue":"1","key":"3494_CR27","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar2362","volume":"10","author":"J Ursum","year":"2008","unstructured":"Ursum J, Nielen MM, van Schaardenburg D, van der Horst AR, van de Stadt RJ, Dijkmans BA, Hamann D (2008) Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthritis Res Ther 10(1):R12. doi: 10.1186\/ar2362","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3494_CR28","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2008","volume":"8","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 8(4):R119","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3494_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00296-008-0614-8","volume":"29","author":"R Sghiri","year":"2008","unstructured":"Sghiri R, Bouajina E, Bargaoui D, Harzallah L, Fredj HB, Sammoud S, Ghedira I (2008) Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatol Int 29(1):59\u201362. doi: 10.1007\/s00296-008-0614-8","journal-title":"Rheumatol Int"},{"issue":"3","key":"3494_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3899\/jrheum.080656","volume":"36","author":"N Mutlu","year":"2009","unstructured":"Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI (2009) Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol 36(3):491\u2013500. doi: 10.3899\/jrheum.080656","journal-title":"J Rheumatol"},{"issue":"2\u20133","key":"3494_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12026-013-8425-8","volume":"56","author":"Z Szekanecz","year":"2013","unstructured":"Szekanecz Z, Szab\u00f3 Z, Zeher M, So\u00f3s L, Dank\u00f3 K, Horv\u00e1th I, Lakos G (2013) Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population. Immunol Res 56(2\u20133):439\u2013443. doi: 10.1007\/s12026-013-8425-8","journal-title":"Immunol Res"},{"issue":"5","key":"3494_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00296-009-1336-2","volume":"31","author":"K Shidara","year":"2011","unstructured":"Shidara K, Inoue E, Tanaka E, Hoshi D, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H (2011) Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int 31(5):617\u2013622. doi: 10.1007\/s00296-009-1336-2","journal-title":"Rheumatol Int"},{"issue":"5","key":"3494_CR33","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, Holers VM, Robinson WH (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7(5):e35296. doi: 10.1371\/journal.pone.0035296","journal-title":"PLoS One"},{"issue":"5","key":"3494_CR34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.berh.2006.06.005","volume":"20","author":"LH Meyer","year":"2006","unstructured":"Meyer LH, Franssen L, Pap T (2006) The role of mesenchymal cells in the pathophysiology of inflammatory arthritis. Best Pract Res Clin Rheumatol 20(5):969\u2013981","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"3494_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/annrheumdis-2014-205698","volume":"75","author":"A Kastbom","year":"2016","unstructured":"Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K (2016) Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis 75(2):356\u2013361. doi: 10.1136\/annrheumdis-2014-205698","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3494_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","volume":"50","author":"DP Rooy de","year":"2011","unstructured":"de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH (2011) Predicting arthritis outcomes\u2014what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 50(1):93\u2013100. doi: 10.1093\/rheumatology\/keq230","journal-title":"Rheumatology"},{"issue":"3","key":"3494_CR37","doi-asserted-by":"crossref","first-page":"R592","DOI":"10.1186\/ar1719","volume":"7","author":"G Boire","year":"2005","unstructured":"Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, M\u00e9nard HA (2005) Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Res Ther 7(3):R592\u2013R603","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3494_CR38","doi-asserted-by":"publisher","first-page":"e000180","DOI":"10.1136\/rmdopen-2015-000180","volume":"1","author":"Y Degbo\u00e9","year":"2015","unstructured":"Degbo\u00e9 Y, Constantin A, Nigon D, Tobon G, Cornillet M, Schaeverbeke T, Chiocchia G, Nicaise-Roland P, Nogueira L, Serre G, Cantagrel A, Ruyssen-Witrand A (2015) Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1\u00a0year: results from the ESPOIR cohort. RMD Open 1(1):e000180. doi: 10.1136\/rmdopen-2015-000180","journal-title":"RMD Open"},{"issue":"2","key":"3494_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/ard.2009.113092","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen SW, Goll GL, van der Heijde D, Landewe R, Lie BA, Odegard S, Uhlig T, Gaarder PI, Kvien TK (2010) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69(2):345\u2013351. doi: 10.1136\/ard.2009.113092","journal-title":"Ann Rheum Dis"},{"key":"3494_CR40","doi-asserted-by":"publisher","first-page":"728610","DOI":"10.1155\/2015\/728610","volume":"2015","author":"AA Jilani","year":"2015","unstructured":"Jilani AA, Mackworth-Young CG (2015) The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol 2015:728610. doi: 10.1155\/2015\/728610","journal-title":"Int J Rheumatol"},{"issue":"5","key":"3494_CR41","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122(5):1791\u20131802. doi: 10.1172\/JCI60975","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"3494_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2011.10.020","volume":"413","author":"AT Kuna","year":"2012","unstructured":"Kuna AT (2012) Mutated citrullinated vimentin antibodies in rheumatoid arthritis. Clin Chim Acta 413(1\u20132):66\u201373. doi: 10.1016\/j.cca.2011.10.020","journal-title":"Clin Chim Acta"},{"issue":"2","key":"3494_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cei.12677","volume":"182","author":"Z Reyes-Castillo","year":"2015","unstructured":"Reyes-Castillo Z, Palafox-S\u00e1nchez CA, Parra-Rojas I, Mart\u00ednez-Bonilla GE, del Toro-Arreola S, Ram\u00edrez-Due\u00f1as MG, Ocampo-Bermudes G, Mu\u00f1oz-Valle JF (2015) Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol 182(2):119\u2013131. doi: 10.1111\/cei.12677","journal-title":"Clin Exp Immunol"},{"key":"3494_CR44","doi-asserted-by":"publisher","first-page":"536050","DOI":"10.1155\/2014\/536050","volume":"2014","author":"L Gonzalez-Lopez","year":"2014","unstructured":"Gonzalez-Lopez L, Rocha-Mu\u00f1oz AD, Ponce-Guarneros M, Flores-Chavez A, Salazar-Paramo M, Nava A, Cardona-Mu\u00f1oz EG, Fajardo-Robledo NS, Zavaleta-Mu\u00f1iz SA, Garcia-Cobian T, Gamez-Nava JI (2014) Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis. J Immunol Res 2014:536050. doi: 10.1155\/2014\/536050","journal-title":"J Immunol Res"},{"issue":"1\u20132","key":"3494_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2014.02.002","volume":"152","author":"R Vassallo","year":"2014","unstructured":"Vassallo R, Luckey D, Behrens M, Madden B, Luthra H, David C, Taneja V (2014) Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes. Clin Immunol 152(1\u20132):25\u201335. doi: 10.1016\/j.clim.2014.02.002","journal-title":"Clin Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3494-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:40:02Z","timestamp":1498354802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3494-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3494"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3494-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}